project id: TCGA-LUAD; case submitter id: TCGA-86-A4P8; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 59; days to birth: -21738; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1953; age at diagnosis: 21738; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T1b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 805.0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: No; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 98; days to sample procurement: 0; initial weight: 360.0; portion submitter id: TCGA-86-A4P8-01A-11; percent lymphocyte infiltration: 8.0; percent monocyte infiltration: 5.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 90.0; percent stromal cells: 0.0; percent tumor cells: 10.0; percent tumor nuclei: 60.0;